Alkahest is a clinical stage company with multiple therapeutic candidates in Phase 2 trials. The company is hoping to develop a treatment for patients with Alzheimer’s but is taking a different path. Alkahest is looking at the plasma proteome and, specifically, how it changes with age.
AI And Machine Learning Help Unravel The Biology Of Alzheimer’s
By Michael Tattory|
2019-10-21T12:30:50-04:00
October 8th, 2019|News|Comments Off on AI And Machine Learning Help Unravel The Biology Of Alzheimer’s